Page 40 Volume 13 - N.4 - 2005

A. Sarmento: A Dor no Doente de Cuidados Intensivos
a
60 mg/dia no idoso e os 90 mg/dia nos outros. 10. Marino PL. Analgesia and sedation. Em: The ICU Book. 2. ed.
Williams & Wilkins; 1998. p. 121-9.
Não deve ser usado durante mais de dois dias 11. Bennett D, Burton AW, Fishman S, et al. Consensus panel recom-
seguidos 10,15 . mendations for the assessment and management of breakthrough
O uso combinado de paracetamol com um pain. Part I assessment. P&T 2005;30:296-301.
opióide produz maior efeito do que o opióide 12. Gutstein HB, Akil H. Opioid analgesics. Em: Goodman & Gilman’s
a
isolado . Deve estar-se atento a hepatotoxicida- The Pharmacological Basis of Therapeutics. 10. ed. McGraw Hill;
23
2001. p. 569-619.
de, particularmente em doentes com história 13. Tavares JC. Analgésicos de acção central e seus antagonistas. Em:
prévia de ingestão alcoólica ou com um mau Terapêutica Medicamentosa e suas Bases Farmacológicas. 4. ed.
a
Porto Editora; 2001. p. 163-78.
estado nutricional. 14. Lambert DG. Recent advances in opioid pharmacology (Editorial).
Br J Anaesthes 1988;81:1-2.
Bibliografia 15. Park JR. Skills and techniques: sedation. Em: PACT (Patient-Centred
Acute Care Training). Ledinghan IM, European Society of Intensive
1. Granja C, Lopes A, Moreira S, et al. Patient’s recollections of expe- Care Medicine, eds.
riences in the intensive care unit may affect their quality of life. Crit 16. Liu S, Carpenter RS, Neal JM. Epidural anaesthesia and analgesia.
Care 2005;9:R96-109. Anesthesiology 1995;82:1474-506.
2. Donovan M, Dillon P, Mcguire L. Incidence and characteristics of pain 17. Bailey PL. The use of opioids in anaesthesia is not especially asso-
in a sample of medical-surgical inpatients. Pain 1987;30:69-78. ciated with nor predictive of postoperative hypoxemia. Anaesthesio-
3. Puntillo KA. Pain experience in ICU patients. Heart Lung 1990;19: logy 1992;77:1235.
526-33. 18. Bosscha K, Nieuwenhuijs VB, Vos A, et al. Gastointestinal motility
4. Paiement B, Boulanger M, Jones CW, Roy M. Intubation and other and gastric tube feeding in mechanically ventilated patients. Crit
experiences in cardiac surgery: the consumer’s views. Can Anesth Care Med 1998;26:1510-7.
Soc J 1979;26:173-80. 19. Pearce CJ, Gonzalez FM, Wallin JD. Renal failure and hiperkalemia
5. Jacobi J, Fraser JL, Coursin DB, et al. Clinical practice guidelines associated with ketorolac tromethamine. Arch Intern Med 1993;
for the sustained use of sedatives and analgesics in the critically ill 153:1000-2.
adult. Crit Care Med 2002;30:119-41. 20. Scholondorff D. Renal complications of non-steroidal anti-inflamatory
6. Epsetein J, Breslow MJ. The stress response of critical illness. Crit drugs. Kidney Int 1993;11:613-53.
Care Clin 1999;15:17-33. 21. Feldman HI, Kinman JL, Berlin JA, et al. Parenteral Ketorolac: The
7. Lewis KS, Whipple JK, Michael KA, et al. Effect of analgesic treat- risk for acute renal failure. Ann Intern Med 1997;126:193-9.
ment on physiological consequences of acute pain. Am J Hosp 22. Strem BL, Berlin JA, Kinmam JL, et al. Parenteral ketorolac and
Pharm 1994;51:1539-54. risk of gastrointestinal and operative site bleeding. JAMA 1996;
8. Desai PM. Pain management and pulmonary dysfunction. Crit Care 275:376-82.
Clin 1999;15:151-66. 23. Peduta VA, Ballahin M, Stefanini S. Efficacy of propacetamol in the
9. Gust R, Pecher S, Gust A, et al. Effect of patient-controlled analge- treatment of postoperative pain. Morphine sparing effect in ortho-
sia on pulmonary complications after coronary artery-bypass graf- paedic surgery. Italian Collaborative Group on Propacetamol. Acta
ting. Crit Care Med 1999;27:2221-3. Anesthesiol Scand 1998;12:293-8.

DOR

39